Brief: Biomerica Expects Patient Enrollment Completion For IBS Treatment Trial This Week
30/08/2021 13:22
Aug 30 (Reuters) - Biomerica Inc BMRA.O :
* BIOMERICA EXPECTS COMPLETION OF PATIENT ENROLLMENT FOR ITS
INFOODS® DIAGNOSTIC-GUIDED THERAPY IRRITABLE BOWEL SYNDROME
CLINICAL TRIAL THIS WEEK
Source text for Eikon: ID:nGNX8psfP4
Further company coverage: BMRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biomerica
See all newsDiagnostics firm Biomerica's Q1 revenue drops on lower clinical lab orders
Brief: Biomerica May Offer Up To $250 Million Of Common Stock, Preferred Stock, Debt Securities, & Warrants
Brief: Biomerica Lands $1.75 Million CDMO Master Services Agreement For IVD Diagnostic Development
Biomerica's Q3 revenue falls, net loss widens on lower manufacturing sales
Brief: Biomerica Q3 Net Income USD -1.31 Million